Clinical trial Recruiting at 4 sites Observational Ages 18 to 60 Men only

Evaluating a new method for sperm capacitation

Official title: Efficacy and Safety of a New Sperm Capacitation Method: a Prospective in Vitro Study on Semen Samples

Run by Fecundis Lab SL · NCT06742437 · Data updated 2026-11-12

This study is testing a new method called HyperSperm to see if it can improve sperm quality for men who are having trouble with fertility.

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexMen only
Enrollment300 (estimated)
SponsorFecundis Lab SL
Academic / other
Locations4 sites (Barcelona, Barcelona and 3 other locations)
StatusRecruiting
StartedJanuary 14, 2025
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedSeptember 1, 2026
Trial IDNCT06742437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are men who can provide a semen sample and are experiencing male infertility or related sperm quality issues.

Probably not a fit

Patients currently diagnosed with sexually transmitted infections or those who have participated in a clinical trial involving an intervention within the last 3 months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the efficacy and safety of a new sperm capacitation method called HyperSperm. It involves a prospective, multicenter design where 300 semen samples with various characteristics and abnormalities will be analyzed over a 12-month period. The study utilizes a split-sample approach, comparing standard sperm preparation with the new method without any intervention. The goal is to gather data on how well HyperSperm performs in improving sperm quality for men facing reproductive issues.

Why it matters

Potential benefit: If successful, this study could provide a new method to enhance sperm quality, potentially improving fertility outcomes for men with reproductive issues.

How similar studies have gone: While this approach is innovative, it is unclear if similar studies have shown success, as this specific method has not been widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to provide a semen sample via masturbation

Exclusion Criteria:

* Current diagnosis of a sexually transmitted infection (STI)
* Previous diagnosis of hepatitis A, B, C, D, or HIV
* Prior participation in this study
* Participation in a clinical trial involving an intervention within the last 3 months

Where it's running

  • Eugin Barcelona
    Barcelona, Barcelona, Spain
    Recruiting
  • Fertty
    Barcelona, Barcelona, Spain
    Recruiting
  • Cirh
    Barcelona, Barcelona, Spain
    Recruiting
  • Natuvitro
    Barcelona, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.